1-12 of 12
Øyvind Hjertner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incidence and Survival of Multiple Myeloma; A Population-Based Study on 10 961 Patients Diagnosed 1982-2017

Øystein Langseth, MD, Tor Åge Myklebust, M.sc, PhD, Tom Børge Johannesen, MD PhD, Øyvind Hjertner, MD PhD, Anders Waage, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4380.
https://doi.org/10.1182/blood-2019-129816
Published: 2019
Journal Articles

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Clinical Trials & Observations
Ulf-Henrik Mellqvist, Peter Gimsing, Oyvind Hjertner, Stig Lenhoff, Edward Laane, Kari Remes, Hlif Steingrimsdottir, Niels Abildgaard, Lucia Ahlberg, Cecilie Blimark, Inger Marie Dahl, Karin Forsberg, Tobias Gedde-Dahl, Henrik Gregersen, Astrid Gruber, Nina Guldbrandsen, Einar Haukås, Kristina Carlson, Ann Kristin Kvam, Hareth Nahi, Roald Lindås, Niels Frost Andersen, Ingemar Turesson, Anders Waage, Jan Westin
Journal: Blood
Blood (2013) 121 (23): 4647–4654.
https://doi.org/10.1182/blood-2012-11-464503
Published: 2013
Journal Articles

A Phase II Study of Bortezomib-Dexametason Followed by High-Dose Melphalan Combined with Bortezomib in Patients Relapsing After High-Dose Melphalan with Autologous Stem Cell Support

Peter Gimsing, MD, DMSci, Assoc. Prof., Oyvind Hjertner, Niels Abildgaard, Niels Frost Andersen, Tobias Gedde Dahl, Henrik Gregersen, MD, Ulf-Henrik Mellqvist, MD, PhD, Olle Linder, Roald Lindas, Niels-Aage Tøfner Clausen, Stig Lenhoff
Journal: Blood
Blood (2011) 118 (21): 3073.
https://doi.org/10.1182/blood.V118.21.3073.3073
Published: 2011
Journal Articles

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

Clinical Trials & Observations
Anders Waage, Peter Gimsing, Peter Fayers, Niels Abildgaard, Lucia Ahlberg, Bo Björkstrand, Kristina Carlson, Inger Marie Dahl, Karin Forsberg, Nina Gulbrandsen, Einar Haukås, Øyvind Hjertner, Martin Hjorth, Torbjörn Karlsson, Lene Meldgaard Knudsen, Johan Lanng Nielsen, Olle Linder, Ulf-Henrik Mellqvist, Ingerid Nesthus, Jürgen Rolke, Maria Strandberg, Jon Hjalmar Sørbø, Finn Wisløff, Gunnar Juliusson, Ingemar Turesson, for the Nordic Myeloma Study Group
Journal: Blood
Blood (2010) 116 (9): 1405–1412.
https://doi.org/10.1182/blood-2009-08-237974
Published: 2010
Journal Articles

Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial.

Ulf-Henrik Mellqvist, MD, PhD, Jan Westin, MD, PhD, Peter Gimsing, DO, PhD, Oyvind Hjertner, Stig Lenhoff, MD, PhD, Edward Laane, Kari Remes, MD, PhD, Hlif Steingrimsdottir, Niels Abildgaard, Lucia Ahlberg, Kristina Carlsson, Inge Marie Dahl, Karin Forsberg, Tobias Gedde-Dahl, MD, PhD, Henrik Gregersen, Astrid Gruber, MD, PhD, Nina Guldbrandsen, Einar Haukås, Olle Linder, Hareth Nahi, Ingerid Nesthus, Nilsaage Toffner-Clausen, Raija Silvennoinen, Niels Frost Andersen, MD, Ingemar Turesson, MD, PhD, Anders Waage, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 530.
https://doi.org/10.1182/blood.V114.22.530.530
Published: 2009
Journal Articles

HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma

Therese Standal, Niels Abildgaard, Unn-Merete Fagerli, Berit Stordal, Øyvind Hjertner, Magne Borset, Anders Sundan
Journal: Blood
Blood (2006) 109 (7): 3024–3030.
https://doi.org/10.1182/blood-2006-07-034884
Published: 2006
Includes: Supplemental data
Journal Articles

HGF Inhibits BMP-Induced Osteoblastogenesis: Implications for the Bone Disease in Multiple Myeloma.

Therese Standal, Niels Abildgaard, Unn-Merete Fagerli, Berit Stordal, Oyvind Hjertner, Magne Borset, Anders Sundan
Journal: Blood
Blood (2006) 108 (11): 3451.
https://doi.org/10.1182/blood.V108.11.3451.3451
Published: 2006
Journal Articles

Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells

Therese Standal, Carina Seidel, Øyvind Hjertner, Torben Plesner, Ralph D. Sanderson, Anders Waage, Magne Borset, Anders Sundan
Journal: Blood
Blood (2002) 100 (8): 3002–3007.
https://doi.org/10.1182/blood-2002-04-1190
Published: 2002
Journal Articles

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease

Brief Report
Carina Seidel, Øyvind Hjertner, Niels Abildgaard, Lene Heickendorff, Martin Hjorth, Jan Westin, Johan Lanng Nielsen, Henrik Hjorth-Hansen, Anders Waage, Anders Sundan, Magne Børset
Journal: Blood
Blood (2001) 98 (7): 2269–2271.
https://doi.org/10.1182/blood.V98.7.2269
Published: 2001
Journal Articles

High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity

Carina Seidel, Magne Børset, Øyvind Hjertner, Dianjun Cao, Niels Abildgaard, Henrik Hjorth-Hansen, Ralph D. Sanderson, Anders Waage, Anders Sundan
Journal: Blood
Blood (2000) 96 (9): 3139–3146.
https://doi.org/10.1182/blood.V96.9.3139
Published: 2000
Journal Articles

Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins

Magne Børset, Øyvind Hjertner, Shmuel Yaccoby, Joshua Epstein, Ralph D. Sanderson
Journal: Blood
Blood (2000) 96 (7): 2528–2536.
https://doi.org/10.1182/blood.V96.7.2528
Published: 2000
Journal Articles

Hepatocyte Growth Factor (HGF) Induces Interleukin-11 Secretion From Osteoblasts: A Possible Role for HGF in Myeloma-Associated Osteolytic Bone Disease

Øyvind Hjertner, Maria Lyngaas Torgersen, Carina Seidel, Henrik Hjorth-Hansen, Anders Waage, Magne Børset, Anders Sundan
Journal: Blood
Blood (1999) 94 (11): 3883–3888.
https://doi.org/10.1182/blood.V94.11.3883
Published: 1999